Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03144232 · ClinicalTrials.gov registry record · Phase 2

A Preliminary Investigation of Pre-Frontal Repetitive Transcranial Magnetic Stimulation (rTMS) for the Treatment of Cannabis Use Disorder

A Phase 2 study of Cannabis Use Disorder, sponsored by Stanford University.

Completed
Registry status
Phase 2
Development phase
72
Enrollment target
1
Study location

NCT03144232 is a Phase 2 study of Cannabis Use Disorder that has completed, run by Stanford University. The registered enrollment target is 72 participants, below the 107-participant average among 34 other Cannabis Use Disorder trials with a reported enrollment target (33% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03144232, a Phase 2 study of Cannabis Use Disorder, has completed, sponsored by Stanford University.

COMPLETED
Registry status
Phase 2
Development phase
72 participants
Enrollment target
1
Study location

Study Summary

This investigation will preliminarily determine if a course of high-frequency rTMS applied to the left dorsolateral prefrontal cortex, will reduce behavioral craving, and fMRI cue-reactivity in treatment-seeking cannabis use disordered participants.

Conditions Studied

Cannabis Use Disorder

Interventions

  • DEVICE Active rTMS
  • DEVICE Sham rTMS

Study Locations (1)

California

  • Stanford University - Palo Alto

Trial Details

FieldValue
Enrollment Target 72 participants
Start Date 2017-08-01
Est. Completion 2022-07-30
Phase Phase 2

Sponsor

Stanford University

1,744 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT03144232

The ClinicalTrials.gov registry entry for NCT03144232 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 72 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 107-participant average among 34 other Cannabis Use Disorder trials with a reported enrollment target (33% lower). The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Cannabis Use Disorder appearing as the primary indexed condition, and to 2 interventions - of which Active rTMS is the first listed.

NCT03144232 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT03144232 about?

NCT03144232 is a clinical study titled "A Preliminary Investigation of Pre-Frontal Repetitive Transcranial Magnetic Stimulation (rTMS) for the Treatment of Cannabis Use Disorder". This investigation will preliminarily determine if a course of high-frequency rTMS applied to the left dorsolateral prefrontal cortex, will reduce behavioral craving, and fMRI cue-reactivity in treatment-seeking cannabis use disordered participants.

What is the current status of trial NCT03144232?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 72 participants. The study started on 2017-08-01. Estimated completion is 2022-07-30.

What conditions does trial NCT03144232 study?

This clinical trial studies the following conditions: Cannabis Use Disorder.

What interventions are being tested in trial NCT03144232?

The interventions under investigation include: Active rTMS (DEVICE), Sham rTMS (DEVICE).

Who is sponsoring clinical trial NCT03144232?

This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03144232 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Cannabis Use Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Cannabis Use Disorder

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.